Global Automation in Biopharmaceutical Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
ReportID: 544157
|
Published Date: 2024/07/06
|
No. of Pages: 165
|
Categories: Automotive & Transportation
|
Format : 
The global Automation in Biopharmaceutical market was valued at 106.7 Million USD in 2020 and will grow with a CAGR of 6.12% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.” According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization. Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer`s disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing.
By Market Verdors:
Danaher
GE
PerkinElmer
Tecan Trading
Thermo Fisher Scientific
Bruker
Peak Analysis & Automation
Waters
Capsugel
RheoSense
Eirechrom
BioProcess International
Novasep
By Types:
Clinical stage automation
Drug discovery stage automation
By Applications:
Research and Development
Clinical
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.” According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization. Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer`s disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing.
By Market Verdors:
Danaher
GE
PerkinElmer
Tecan Trading
Thermo Fisher Scientific
Bruker
Peak Analysis & Automation
Waters
Capsugel
RheoSense
Eirechrom
BioProcess International
Novasep
By Types:
Clinical stage automation
Drug discovery stage automation
By Applications:
Research and Development
Clinical
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Automation in Biopharmaceutical Revenue
1.4 Market Analysis by Type
1.4.1 Global Automation in Biopharmaceutical Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Clinical stage automation
1.4.3 Drug discovery stage automation
1.5 Market by Application
1.5.1 Global Automation in Biopharmaceutical Market Share by Application: 2022-2027
1.5.2 Research and Development
1.5.3 Clinical
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Automation in Biopharmaceutical Market
1.8.1 Global Automation in Biopharmaceutical Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Automation in Biopharmaceutical Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Automation in Biopharmaceutical Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Automation in Biopharmaceutical Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Automation in Biopharmaceutical Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Automation in Biopharmaceutical Sales Volume Market Share by Region (2016-2021)
3.2 Global Automation in Biopharmaceutical Sales Revenue Market Share by Region (2016-2021)
3.3 North America Automation in Biopharmaceutical Sales Volume
3.3.1 North America Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.3.2 North America Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Automation in Biopharmaceutical Sales Volume
3.4.1 East Asia Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Automation in Biopharmaceutical Sales Volume (2016-2021)
3.5.1 Europe Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Automation in Biopharmaceutical Sales Volume (2016-2021)
3.6.1 South Asia Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Automation in Biopharmaceutical Sales Volume (2016-2021)
3.7.1 Southeast Asia Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Automation in Biopharmaceutical Sales Volume (2016-2021)
3.8.1 Middle East Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Automation in Biopharmaceutical Sales Volume (2016-2021)
3.9.1 Africa Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Automation in Biopharmaceutical Sales Volume (2016-2021)
3.10.1 Oceania Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Automation in Biopharmaceutical Sales Volume (2016-2021)
3.11.1 South America Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.11.2 South America Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Automation in Biopharmaceutical Sales Volume (2016-2021)
3.12.1 Rest of the World Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Automation in Biopharmaceutical Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Automation in Biopharmaceutical Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Automation in Biopharmaceutical Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Automation in Biopharmaceutical Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Automation in Biopharmaceutical Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Automation in Biopharmaceutical Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Automation in Biopharmaceutical Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Automation in Biopharmaceutical Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Automation in Biopharmaceutical Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Automation in Biopharmaceutical Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Automation in Biopharmaceutical Sales Volume Market Share by Type (2016-2021)
14.2 Global Automation in Biopharmaceutical Sales Revenue Market Share by Type (2016-2021)
14.3 Global Automation in Biopharmaceutical Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Automation in Biopharmaceutical Consumption Volume by Application (2016-2021)
15.2 Global Automation in Biopharmaceutical Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Automation in Biopharmaceutical Business
16.1 Danaher
16.1.1 Danaher Company Profile
16.1.2 Danaher Automation in Biopharmaceutical Product Specification
16.1.3 Danaher Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 GE
16.2.1 GE Company Profile
16.2.2 GE Automation in Biopharmaceutical Product Specification
16.2.3 GE Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 PerkinElmer
16.3.1 PerkinElmer Company Profile
16.3.2 PerkinElmer Automation in Biopharmaceutical Product Specification
16.3.3 PerkinElmer Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Tecan Trading
16.4.1 Tecan Trading Company Profile
16.4.2 Tecan Trading Automation in Biopharmaceutical Product Specification
16.4.3 Tecan Trading Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Thermo Fisher Scientific
16.5.1 Thermo Fisher Scientific Company Profile
16.5.2 Thermo Fisher Scientific Automation in Biopharmaceutical Product Specification
16.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Bruker
16.6.1 Bruker Company Profile
16.6.2 Bruker Automation in Biopharmaceutical Product Specification
16.6.3 Bruker Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Peak Analysis & Automation
16.7.1 Peak Analysis & Automation Company Profile
16.7.2 Peak Analysis & Automation Automation in Biopharmaceutical Product Specification
16.7.3 Peak Analysis & Automation Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Waters
16.8.1 Waters Company Profile
16.8.2 Waters Automation in Biopharmaceutical Product Specification
16.8.3 Waters Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Capsugel
16.9.1 Capsugel Company Profile
16.9.2 Capsugel Automation in Biopharmaceutical Product Specification
16.9.3 Capsugel Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 RheoSense
16.10.1 RheoSense Company Profile
16.10.2 RheoSense Automation in Biopharmaceutical Product Specification
16.10.3 RheoSense Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Eirechrom
16.11.1 Eirechrom Company Profile
16.11.2 Eirechrom Automation in Biopharmaceutical Product Specification
16.11.3 Eirechrom Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 BioProcess International
16.12.1 BioProcess International Company Profile
16.12.2 BioProcess International Automation in Biopharmaceutical Product Specification
16.12.3 BioProcess International Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Novasep
16.13.1 Novasep Company Profile
16.13.2 Novasep Automation in Biopharmaceutical Product Specification
16.13.3 Novasep Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Automation in Biopharmaceutical Manufacturing Cost Analysis
17.1 Automation in Biopharmaceutical Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Automation in Biopharmaceutical
17.4 Automation in Biopharmaceutical Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Automation in Biopharmaceutical Distributors List
18.3 Automation in Biopharmaceutical Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Automation in Biopharmaceutical (2022-2027)
20.2 Global Forecasted Revenue of Automation in Biopharmaceutical (2022-2027)
20.3 Global Forecasted Price of Automation in Biopharmaceutical (2016-2027)
20.4 Global Forecasted Production of Automation in Biopharmaceutical by Region (2022-2027)
20.4.1 North America Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.3 Europe Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.7 Africa Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.9 South America Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Automation in Biopharmaceutical by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Automation in Biopharmaceutical by Country
21.2 East Asia Market Forecasted Consumption of Automation in Biopharmaceutical by Country
21.3 Europe Market Forecasted Consumption of Automation in Biopharmaceutical by Countriy
21.4 South Asia Forecasted Consumption of Automation in Biopharmaceutical by Country
21.5 Southeast Asia Forecasted Consumption of Automation in Biopharmaceutical by Country
21.6 Middle East Forecasted Consumption of Automation in Biopharmaceutical by Country
21.7 Africa Forecasted Consumption of Automation in Biopharmaceutical by Country
21.8 Oceania Forecasted Consumption of Automation in Biopharmaceutical by Country
21.9 South America Forecasted Consumption of Automation in Biopharmaceutical by Country
21.10 Rest of the world Forecasted Consumption of Automation in Biopharmaceutical by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Automation in Biopharmaceutical Revenue
1.4 Market Analysis by Type
1.4.1 Global Automation in Biopharmaceutical Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Clinical stage automation
1.4.3 Drug discovery stage automation
1.5 Market by Application
1.5.1 Global Automation in Biopharmaceutical Market Share by Application: 2022-2027
1.5.2 Research and Development
1.5.3 Clinical
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Automation in Biopharmaceutical Market
1.8.1 Global Automation in Biopharmaceutical Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Automation in Biopharmaceutical Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Automation in Biopharmaceutical Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Automation in Biopharmaceutical Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Automation in Biopharmaceutical Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Automation in Biopharmaceutical Sales Volume Market Share by Region (2016-2021)
3.2 Global Automation in Biopharmaceutical Sales Revenue Market Share by Region (2016-2021)
3.3 North America Automation in Biopharmaceutical Sales Volume
3.3.1 North America Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.3.2 North America Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Automation in Biopharmaceutical Sales Volume
3.4.1 East Asia Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Automation in Biopharmaceutical Sales Volume (2016-2021)
3.5.1 Europe Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Automation in Biopharmaceutical Sales Volume (2016-2021)
3.6.1 South Asia Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Automation in Biopharmaceutical Sales Volume (2016-2021)
3.7.1 Southeast Asia Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Automation in Biopharmaceutical Sales Volume (2016-2021)
3.8.1 Middle East Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Automation in Biopharmaceutical Sales Volume (2016-2021)
3.9.1 Africa Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Automation in Biopharmaceutical Sales Volume (2016-2021)
3.10.1 Oceania Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Automation in Biopharmaceutical Sales Volume (2016-2021)
3.11.1 South America Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.11.2 South America Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Automation in Biopharmaceutical Sales Volume (2016-2021)
3.12.1 Rest of the World Automation in Biopharmaceutical Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Automation in Biopharmaceutical Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Automation in Biopharmaceutical Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Automation in Biopharmaceutical Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Automation in Biopharmaceutical Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Automation in Biopharmaceutical Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Automation in Biopharmaceutical Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Automation in Biopharmaceutical Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Automation in Biopharmaceutical Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Automation in Biopharmaceutical Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Automation in Biopharmaceutical Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Automation in Biopharmaceutical Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Automation in Biopharmaceutical Sales Volume Market Share by Type (2016-2021)
14.2 Global Automation in Biopharmaceutical Sales Revenue Market Share by Type (2016-2021)
14.3 Global Automation in Biopharmaceutical Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Automation in Biopharmaceutical Consumption Volume by Application (2016-2021)
15.2 Global Automation in Biopharmaceutical Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Automation in Biopharmaceutical Business
16.1 Danaher
16.1.1 Danaher Company Profile
16.1.2 Danaher Automation in Biopharmaceutical Product Specification
16.1.3 Danaher Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 GE
16.2.1 GE Company Profile
16.2.2 GE Automation in Biopharmaceutical Product Specification
16.2.3 GE Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 PerkinElmer
16.3.1 PerkinElmer Company Profile
16.3.2 PerkinElmer Automation in Biopharmaceutical Product Specification
16.3.3 PerkinElmer Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Tecan Trading
16.4.1 Tecan Trading Company Profile
16.4.2 Tecan Trading Automation in Biopharmaceutical Product Specification
16.4.3 Tecan Trading Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Thermo Fisher Scientific
16.5.1 Thermo Fisher Scientific Company Profile
16.5.2 Thermo Fisher Scientific Automation in Biopharmaceutical Product Specification
16.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Bruker
16.6.1 Bruker Company Profile
16.6.2 Bruker Automation in Biopharmaceutical Product Specification
16.6.3 Bruker Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Peak Analysis & Automation
16.7.1 Peak Analysis & Automation Company Profile
16.7.2 Peak Analysis & Automation Automation in Biopharmaceutical Product Specification
16.7.3 Peak Analysis & Automation Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Waters
16.8.1 Waters Company Profile
16.8.2 Waters Automation in Biopharmaceutical Product Specification
16.8.3 Waters Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Capsugel
16.9.1 Capsugel Company Profile
16.9.2 Capsugel Automation in Biopharmaceutical Product Specification
16.9.3 Capsugel Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 RheoSense
16.10.1 RheoSense Company Profile
16.10.2 RheoSense Automation in Biopharmaceutical Product Specification
16.10.3 RheoSense Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Eirechrom
16.11.1 Eirechrom Company Profile
16.11.2 Eirechrom Automation in Biopharmaceutical Product Specification
16.11.3 Eirechrom Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 BioProcess International
16.12.1 BioProcess International Company Profile
16.12.2 BioProcess International Automation in Biopharmaceutical Product Specification
16.12.3 BioProcess International Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Novasep
16.13.1 Novasep Company Profile
16.13.2 Novasep Automation in Biopharmaceutical Product Specification
16.13.3 Novasep Automation in Biopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Automation in Biopharmaceutical Manufacturing Cost Analysis
17.1 Automation in Biopharmaceutical Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Automation in Biopharmaceutical
17.4 Automation in Biopharmaceutical Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Automation in Biopharmaceutical Distributors List
18.3 Automation in Biopharmaceutical Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Automation in Biopharmaceutical (2022-2027)
20.2 Global Forecasted Revenue of Automation in Biopharmaceutical (2022-2027)
20.3 Global Forecasted Price of Automation in Biopharmaceutical (2016-2027)
20.4 Global Forecasted Production of Automation in Biopharmaceutical by Region (2022-2027)
20.4.1 North America Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.3 Europe Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.7 Africa Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.9 South America Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Automation in Biopharmaceutical Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Automation in Biopharmaceutical by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Automation in Biopharmaceutical by Country
21.2 East Asia Market Forecasted Consumption of Automation in Biopharmaceutical by Country
21.3 Europe Market Forecasted Consumption of Automation in Biopharmaceutical by Countriy
21.4 South Asia Forecasted Consumption of Automation in Biopharmaceutical by Country
21.5 Southeast Asia Forecasted Consumption of Automation in Biopharmaceutical by Country
21.6 Middle East Forecasted Consumption of Automation in Biopharmaceutical by Country
21.7 Africa Forecasted Consumption of Automation in Biopharmaceutical by Country
21.8 Oceania Forecasted Consumption of Automation in Biopharmaceutical by Country
21.9 South America Forecasted Consumption of Automation in Biopharmaceutical by Country
21.10 Rest of the world Forecasted Consumption of Automation in Biopharmaceutical by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Published On:2024/07/06
Base Year:
Historical Data:
No of Pages:165
Price
Global Automation in Biopharmaceutical Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
